Extract from “TPP Threatens Access to Medicines: Statement in Advance of State of the Union”

If passed, the TPP will lock in policies that will keep prices obscenely high.

– The TPP could tie policymakers’ hands by locking in the inability of our government to negotiate reasonable prescription prices in any future Medicare Part D reform.
– The TPP would prevent the reduction of extra-long monopolies for biologic medicines — some of which cost over $100,000 per year — and delay the timely development of affordable, life-saving biosimilars.
– The TPP would lock in perverse incentives that encourage pharmaceutical companies to “evergreen” profits, extending monopolies for making minor modifications to existing medicines rather than developing new medicines.
– In addition, efforts to reform our system and reduce medical costs in the future could be challenged outside our court system in unaccountable trade tribunals.

Loading data

Welcome to TPP Debate!
What's your stance?

TPPDebate.org is a crowd-sourced platform to debate the Trans-Pacific Partnership Agreement (TPP). What does everyone think about the TPP? What is your stance?